Regulation (EU) 2017/1569
Commission Delegated Regulation (EU) 2017/1569 of 23 May 2017 supplementing Regulation (EU) No 536/2014 of the European Parliament and of the Council by specifying principles of and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections (Text with EEA relevance. )
In forceTyperegulationDate23 May 2017Since1 Jan 2018Articles27Versions held47Cited by7 documents
- 3Conformity with good manufacturing practice
- 4Compliance with clinical trial authorisation
- 5Pharmaceutical quality system
- 6Personnel
- 7Premises and equipment
- 8Documentation
- 9Production
- 10Quality control
- 11Retention of samples used for quality control
- 12Responsibilities of the qualified person
- 13Outsourced operations
- 14Complaints, product recall and emergency unblinding
- 15Self-inspection by the manufacturer
- 16Advanced therapy investigational medicinal products
- 17Supervision by inspection
- 18Cooperation and coordination of inspections
- 19Recognition of inspection conclusions
- 20Empowerments of the inspectors
- 21Competence and obligations of the inspectors
- 22Quality system
- 23Impartiality of inspectors
- 24Access to premises
- 25Suspension or revocation of manufacturing authorisation
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).